IR-Med (IRME) Cost of Revenue (2021 - 2025)

IR-Med has disclosed Cost of Revenue across 5 years of filings, most recently posting $1000.0 for Q2 2025.

• Cost of Revenue for Q2 2025 came in at $1000.0, down 96.43% year-over-year; the trailing twelve-month figure through Jun 2025 was $27000.0 (down 96.05% YoY), and the FY2024 annual result was $220000.0, down 73.24% from the prior year.
• Cost of Revenue came in at $1000.0 for Q2 2025 at IR-Med, down from $2000.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $593000.0 in Q2 2021 to a low of -$5000.0 in Q4 2024.
• The 5-year median for Cost of Revenue is $64000.0 (2021), against an average of $148352.9.
• Across the five-year window, Cost of Revenue surged 1137.5% in 2023 and plunged 102.62% in 2024, its largest moves.
• IR-Med's Cost of Revenue stood at $64000.0 in 2021, then soared by 765.62% to $554000.0 in 2022, then tumbled by 65.52% to $191000.0 in 2023, then slumped by 102.62% to -$5000.0 in 2024, then surged by 120.0% to $1000.0 in 2025.
• The last three Cost of Revenue figures came in at $1000.0 (Q2 2025), $2000.0 (Q1 2025), and -$5000.0 (Q4 2024), per Business Quant data.